Client News

Roquefort Therapeutics plc: Investor Presentation
Home / Client News / Roquefort Therapeutics plc: Investor Presentation

Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on early-stage opportunities in the biotechnology sector, is pleased to announce that Executive Chairman Stephen West and proposed new Chief Executive Officer Ajan Reginald will provide a live presentation to discuss the Proposed Acquisition of Oncogeni and Proposed Placing via the Investor Meet Company platform on Friday, 24 June 2022 at 9am BST.


If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.


Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.

Share This